1. Home
  2. AVTX vs BLNK Comparison

AVTX vs BLNK Comparison

Compare AVTX & BLNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVTX
  • BLNK
  • Stock Information
  • Founded
  • AVTX 2011
  • BLNK 2009
  • Country
  • AVTX United States
  • BLNK United States
  • Employees
  • AVTX N/A
  • BLNK N/A
  • Industry
  • AVTX Biotechnology: Pharmaceutical Preparations
  • BLNK Industrial Specialties
  • Sector
  • AVTX Health Care
  • BLNK Consumer Discretionary
  • Exchange
  • AVTX Nasdaq
  • BLNK Nasdaq
  • Market Cap
  • AVTX 88.4M
  • BLNK 105.2M
  • IPO Year
  • AVTX 2015
  • BLNK N/A
  • Fundamental
  • Price
  • AVTX $8.46
  • BLNK $0.94
  • Analyst Decision
  • AVTX Strong Buy
  • BLNK Buy
  • Analyst Count
  • AVTX 7
  • BLNK 8
  • Target Price
  • AVTX $34.33
  • BLNK $3.31
  • AVG Volume (30 Days)
  • AVTX 109.6K
  • BLNK 3.9M
  • Earning Date
  • AVTX 05-12-2025
  • BLNK 03-13-2025
  • Dividend Yield
  • AVTX N/A
  • BLNK N/A
  • EPS Growth
  • AVTX N/A
  • BLNK N/A
  • EPS
  • AVTX N/A
  • BLNK N/A
  • Revenue
  • AVTX $441,000.00
  • BLNK $126,197,000.00
  • Revenue This Year
  • AVTX N/A
  • BLNK $25.90
  • Revenue Next Year
  • AVTX N/A
  • BLNK $35.81
  • P/E Ratio
  • AVTX N/A
  • BLNK N/A
  • Revenue Growth
  • AVTX N/A
  • BLNK N/A
  • 52 Week Low
  • AVTX $5.99
  • BLNK $0.87
  • 52 Week High
  • AVTX $22.47
  • BLNK $3.75
  • Technical
  • Relative Strength Index (RSI)
  • AVTX 56.89
  • BLNK 41.47
  • Support Level
  • AVTX $7.88
  • BLNK $0.98
  • Resistance Level
  • AVTX $9.00
  • BLNK $1.05
  • Average True Range (ATR)
  • AVTX 0.81
  • BLNK 0.07
  • MACD
  • AVTX 0.12
  • BLNK 0.00
  • Stochastic Oscillator
  • AVTX 54.41
  • BLNK 29.01

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical stage biotechnology company focused on the treatment of immune dysregulation. The company's lead asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

About BLNK Blink Charging Co.

Blink Charging Co is an owner, operator, and provider of electric vehicle (EV) charging services. The company offers both residential and commercial EV charging equipment, enabling EV drivers to easily recharge at various location types. The company's business is the sale and distribution of electric vehicle charging equipment and its associated revenues earned from customers and/or Property Partners who use equipment connected to its network. It earns majority revenue from U.S.A.

Share on Social Networks: